1. Home
  2. OGN vs CIVI Comparison

OGN vs CIVI Comparison

Compare OGN & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CIVI
  • Stock Information
  • Founded
  • OGN 1923
  • CIVI 1999
  • Country
  • OGN United States
  • CIVI United States
  • Employees
  • OGN N/A
  • CIVI N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CIVI Oil & Gas Production
  • Sector
  • OGN Health Care
  • CIVI Energy
  • Exchange
  • OGN Nasdaq
  • CIVI Nasdaq
  • Market Cap
  • OGN 4.0B
  • CIVI 3.3B
  • IPO Year
  • OGN N/A
  • CIVI 2011
  • Fundamental
  • Price
  • OGN $13.63
  • CIVI $26.74
  • Analyst Decision
  • OGN Hold
  • CIVI Buy
  • Analyst Count
  • OGN 5
  • CIVI 12
  • Target Price
  • OGN $20.80
  • CIVI $62.20
  • AVG Volume (30 Days)
  • OGN 4.0M
  • CIVI 2.2M
  • Earning Date
  • OGN 05-01-2025
  • CIVI 05-01-2025
  • Dividend Yield
  • OGN 7.75%
  • CIVI 13.71%
  • EPS Growth
  • OGN N/A
  • CIVI N/A
  • EPS
  • OGN 3.33
  • CIVI 8.46
  • Revenue
  • OGN $6,403,000,000.00
  • CIVI $5,206,808,000.00
  • Revenue This Year
  • OGN N/A
  • CIVI N/A
  • Revenue Next Year
  • OGN $0.71
  • CIVI $2.40
  • P/E Ratio
  • OGN $4.34
  • CIVI $3.47
  • Revenue Growth
  • OGN 2.23
  • CIVI 49.65
  • 52 Week Low
  • OGN $13.87
  • CIVI $29.20
  • 52 Week High
  • OGN $23.10
  • CIVI $78.63
  • Technical
  • Relative Strength Index (RSI)
  • OGN 36.36
  • CIVI 28.17
  • Support Level
  • OGN $13.90
  • CIVI $34.60
  • Resistance Level
  • OGN $14.94
  • CIVI $35.13
  • Average True Range (ATR)
  • OGN 0.54
  • CIVI 1.47
  • MACD
  • OGN -0.13
  • CIVI 0.13
  • Stochastic Oscillator
  • OGN 3.23
  • CIVI 1.76

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

Share on Social Networks: